Literature DB >> 13039964

A review of the influence of bacterial infection and of bacterial products (Coley's toxins) on malignant tumors in man; a critical analysis of 30 inoperable cases treated by Coley's mixed toxins, in which diagnosis was confirmed by microscopic examination selected for special study.

H C NAUTS, G A FOWLER, F H BOGATKO.   

Abstract

Entities:  

Keywords:  BACTERIA; BIOLOGICAL PRODUCTS/therapeutic use; NEOPLASMS/therapy

Mesh:

Substances:

Year:  1953        PMID: 13039964

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN: 0365-463X


× No keyword cloud information.
  54 in total

1.  The role of funding and policies on innovation in cancer drug development.

Authors:  P Kanavos; R Sullivan; G Lewison; W Schurer; S Eckhouse; Z Vlachopioti
Journal:  Ecancermedicalscience       Date:  2010-02-03

Review 2.  Beyond cancer vaccines: a reason for future optimism with immunomodulatory therapy.

Authors:  Michael Postow; Margaret K Callahan; Jedd D Wolchok
Journal:  Cancer J       Date:  2011 Sep-Oct       Impact factor: 3.360

3.  [Nanomedicine. Innovative applications in medicine].

Authors:  C Alexiou
Journal:  HNO       Date:  2013-03       Impact factor: 1.284

Review 4.  Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential.

Authors:  Gregory T Wurz; Chiao-Jung Kao; Michael W DeGregorio
Journal:  Ther Adv Med Oncol       Date:  2016-01       Impact factor: 8.168

5.  Current status of immunotherapy for the treatment of lung cancer.

Authors:  Sanjay Murala; Vamsi Alli; Daniel Kreisel; Andrew E Gelman; Alexander S Krupnick
Journal:  J Thorac Dis       Date:  2010-12       Impact factor: 2.895

6.  Role of respiratory-burst products from polymorphonuclear leukocytes in the antitumor activity of Propionibacterium acnes vaccine.

Authors:  E A Murano; C S Cummins
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  Effect of bacterial lipopolysaccharide on growth of murine bladder cancer, MBT-2.

Authors:  K Lee; J F Ewing; P M Sluss
Journal:  Urol Res       Date:  1989

Review 8.  Bacteria in cancer therapy: a novel experimental strategy.

Authors:  S Patyar; R Joshi; D S Prasad Byrav; A Prakash; B Medhi; B K Das
Journal:  J Biomed Sci       Date:  2010-03-23       Impact factor: 8.410

9.  Clinical uses of GM-CSF, a critical appraisal and update.

Authors:  Martha Arellano; Sagar Lonial
Journal:  Biologics       Date:  2008-03

10.  Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent.

Authors:  M B Jameson; P I Thompson; B C Baguley; B D Evans; V J Harvey; D J Porter; M R McCrystal; M Small; K Bellenger; L Gumbrell; G W Halbert; P Kestell
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.